New START site to be established in collaboration with Baptist Health Herbert Wertheim Cancer Institute will bring novel oncology therapies closer to patients across South Florida

Miami,
FL / San Antonio, TX
– May 28, 2026 – Baptist
Health South Florida
and The
START Center for Cancer Research,
the largest global network of fully dedicated, early-phase oncology clinical
trial sites, today announced plans to form a strategic collaboration. A new
START early-phase clinical trial site will be established in collaboration with
Herbert Wertheim Cancer Institute, part of Baptist Health South Florida, giving
patients across South Florida direct access to the most advanced
investigational cancer therapies in the world.
South
Florida represents a significant and growing need for expanded access to early-phase
oncology clinical trials. With more than 130,000 new cancer cases diagnosed
annually across Florida, patients in the region have historically had limited
local access to early-phase studies, often requiring travel outside their communities
to participate. This partnership is designed to bring those opportunities
closer to where patients live and receive care.
The
partnership brings together START's expertise conducting early-phase, oncology
trials and Baptist Health's network of nationally recognized cancer specialists,
anchored by Herbert Wertheim Cancer Institute and Lynn Cancer Institute.
Patients across Baptist Health's system, as well as patients across the region
will have access to investigational therapies close to home.
"START's
mission is to bring the hope of early-phase clinical trials to every community."
said Nick Slack, MBE, Chairman and CEO of START.
"South Florida is home to millions of people who deserve access to the
best cancer research in the world. Most cancer patients are treated in
community settings and START exists to make sure those patients have access to
early-phase clinical trial options. Baptist Health brings not only the scale
and trust of its community, but also a vibrant culture of research that makes
this partnership especially powerful. Together, we are expanding access to novel
therapies and advancing our mission of Hope Through Access."
"Partnering
with START gives patients and physicians access to first-in-class oncology
trials that would otherwise require traveling hundreds of miles. For a
community as large and diverse as ours, that matters enormously,” said Leonard Kalman, M.D., acting system chief executive
of Baptist Health Cancer Care and acting executive medical director of Baptist Health
Herbert Wertheim Cancer Institute. “We look forward to what we will accomplish
together for patients across south Florida."
Baptist
Health is the region's largest not-for-profit health care organization, with 12
hospitals, more than 29,000 employees and more than 200 outpatient facilities
across Miami-Dade, Broward, Palm Beach and Martin counties.
START
operates the largest global network of early-phase clinical trial sites, with
more than 40 world-class Principal Investigators across 15 locations in the United
States and Europe. With nearly 1,000 active studies, START provides access to
one of the most extensive portfolios of industry-sponsored early-phase cancer
trials worldwide. The new Baptist Health site will be fully integrated into the
START network, with access to its global trial portfolio from day one.
About
START
About
Baptist Health South Florida Baptist Health South Florida is the largest healthcare
organization in the region, with 12 hospitals, more than 29,000 employees,
4,500 physicians and 200 outpatient centers, urgent care facilities and
physician practices spanning Miami-Dade, Monroe, Broward and Palm Beach
counties. Baptist Health has internationally renowned institutes specializing
in cancer care, brain and spine care, heart and vascular care and orthopedic
care. In addition, it includes Baptist Health Medical Group; Baptist Health
Quality Network; and the Baptist Health PineApp, a virtual health platform. Baptist
Health South Florida is an academic and clinical affiliate of Florida
International University. A not-for-profit organization supported by
philanthropy and committed to its charitable mission of medical excellence,
Baptist Health has been recognized by Fortune as one of the 100 Best Companies
to Work For in America and is the most awarded healthcare system in South
Florida by U.S. News & World Report. For more information, visit BaptistHealth.net/Newsroom and connect with us
on Facebook, X (formerly Twitter), Instagram, TikTok and LinkedIn.
Deeply rooted in community oncology centers globally, The START Center for
Cancer Research provides access to specialized preclinical and early-phase
clinical trials of novel anti-cancer agents. START clinical trial sites have
conducted more than 1,000 early-phase clinical trials, including for 50
therapies that were approved by the FDA or EMA. START represents the world’s
largest roster of early-phase principal investigators across its 15 clinical
trial sites. Committed to accelerating passage from trials to treatments, START
delivers hope to patients, families, and physicians around the world. Learn
more at STARTresearch.com.